Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Zenith Epigenetics Ltd

By jpalfreyman on Fri, 07/25/2025 - 10:40
  • Read more about Zenith Epigenetics Ltd

Safety and Immunogenicity of NVX-CoV2705

  • Read more about Safety and Immunogenicity of NVX-CoV2705

Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

  • Read more about Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

OS Therapies

By jpalfreyman on Tue, 07/22/2025 - 09:55
  • Read more about OS Therapies

Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing

  • Read more about Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing

Dose Finding Trial of R21/Matrix-M in School Children

  • Read more about Dose Finding Trial of R21/Matrix-M in School Children

Microbial and Cytokine Signatures in Long COVID Patients

  • Read more about Microbial and Cytokine Signatures in Long COVID Patients

Radiofrequency Intervention in Post-COVID-19 Patients With Musculoskeletal Sequelae

  • Read more about Radiofrequency Intervention in Post-COVID-19 Patients With Musculoskeletal Sequelae

Shanton Pharma PTE. LTD.

By jpalfreyman on Mon, 07/21/2025 - 09:52
  • Read more about Shanton Pharma PTE. LTD.

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

  • Read more about A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA